GRASS sits at $0.36055 with RSI 41.5 and a 20.4% 30-day slide
⚖ Verdict rendered 2026-07-24 02:41 UTC
Each grade is scored on its own scale — they are not averaged, by design.
Opinions are AI; settlements are facts. · data powered by VeraMind
snapshot at verdict time, computed from exchange data — facts, not opinions · price = median of 4 exchanges
I’m Leo Vance. I’ll concede the ugly number: GRASS is down 20.4% over 30 days and sits 12.9% below SMA50. But the tape is stretched into fear at 28, RSI is only 41.5 rather than deeply oversold, and the bigger trend still has price 5.3% above SMA200 with SMA50 20.8% higher than SMA200. That’s a pullback inside a surviving uptrend, not a crater—especially with $33M of reported annual AI-customer revenue in the background.
I’m Mara Frost. Leo’s “surviving uptrend” hangs on one number, price versus SMA200, while the market is trading below both SMA20 and SMA50 and has lost 20.4% in a month. His 5.3% SMA200 cushion is thin against a 41.2% collapse from the 60-day high, and the 0.83 taker buy/sell ratio says sellers—not revenue stories—are pressing the button now.
Mara, you’re treating the 60-day high at $0.614 like a sacred baseline. The actual battlefield is closer: $0.3077 support is 17.4% below spot, and fear at 28 can reverse faster than your short thesis can reload.
Leo, $0.3077 isn’t support until buyers defend it; today’s $0.36055 price is already beneath SMA20 and SMA50. A 0.83 taker ratio is the market voting against your rebound story in real time.
Mara, you’re treating the 60-day high at $0.614 like a sacred baseline. The actual battlefield is closer: $0.3077 support is 17.4% below spot, and fear at 28 can reverse faster than your short thesis can reload.
Leo, $0.3077 isn’t support until buyers defend it; today’s $0.36055 price is already beneath SMA20 and SMA50. A 0.83 taker ratio is the market voting against your rebound story in real time.
I’m Theo Okafor. The crowd is not cleanly washed out: 54.9% of long accounts and a 1.22 long/short ratio leave plenty of trapped optimism. Without funding-rate data, I won’t claim crowded leverage, but the available positioning still favors a downside squeeze.
I’m Dmitri Volkov. Macro liquidity is not offering GRASS a free rescue, and the Clarity Act’s delayed window removes a potential sector catalyst. Until price reclaims SMA50, this is a weak asset asking the market to believe a future governance vote.
I’m Judge Aldrich. I award the ruling to the bears, and the decisive exhibit is the 0.83 taker buy/sell ratio alongside a 20.4% 30-day decline. GRASS is vulnerable toward $0.3077; I overturn this ruling only if price reclaims the SMA50 level implied by being 12.9% above current spot, approximately $0.4138, with RSI recovering above 50.
I’m Kai Nakamura. Short-term structure is bearish: price is 7.8% below SMA20 and 12.9% below SMA50, while MACD histogram remains negative at -0.00207. The counterpoint is structural: price is still 5.3% above SMA200 and SMA50 leads SMA200 by 20.8%.
I’m Sofia Reyes. Fear&Greed at 28, taker buy/sell at 0.83, and 54.9% long accounts show a fearful tape with buyers failing to seize control. The 1.22 long/short account ratio means the crowd is still leaning long enough to provide downside fuel.
I’m Ed Walsh. The actionable headline is Grass Phase 2 rewards becoming claimable, while the reported $33M annual AI-customer revenue and July 7 governance vote offer a tangible business narrative. Broader headlines about the Clarity Act and a hacked Robinhood CEO account are market-context noise, not GRASS-specific catalysts.
I’m Priya Anand. The reported $33M per year from AI customers is the strongest fundamental exhibit, and the governance vote on revenue capture could matter if implemented. But the data pack gives no token-supply, valuation, or realized-capture figures, so that narrative cannot yet outweigh the chart’s 30-day 20.4% drawdown.